miR-497 may enhance the sensitivity of non-small cell lung cancer cells to gefitinib through targeting the insulin-like growth factor-1 receptor

BACKGROUND: Recently, studies have demonstrated that microRNA-497 (miR-497) plays an important role in modulating tumor cell sensitivity to chemotherapeutic drugs; however, its role in cellular resistance to the effects of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) in tr...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Thorac Dis
Egile Nagusiak: Ma, Wei, Feng, Weiye, Tan, Jie, Xu, Airu, Hu, Yudong, Ning, Lanlan, Kang, Yanhong, Wang, Liuqian, Zhao, Ziwen
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: AME Publishing Company 2018
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6236188/
https://ncbi.nlm.nih.gov/pubmed/30505497
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2018.10.40
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak